|
|||||
|
Many variations, all much safer than cigarettes – but what does FDA/CDC do about that? Welcome to a new report written by me, Clive Bates, with David Sweanor of Ottawa University, and Eli Lehrer, President of the R Street Institute. The fully designed report is available at R Street with press notice. Reshaping American […] Just when you thought public health could sink no lower, it pulls it off again! This time, a couple of “tobacco control” organisations, CTFK and ENSP, have been writing to several participants in a conference (GTNF 2016) to be held next week. The letters tell them they must be mistaken, that they can’t possibly […] Death by paperwork: no estimate has been made of the damage that paperwork burdens will do Under the Tobacco Products Directive Article 20(2), e-cigarette and e-liquid manufacturers or importers will have to notify the authorities of any product they want to place on the market. A low-key (to put it mildly) UK consultation […] Misleading labels implicitly exaggerating risk? These are the current U.S. snus warnings What sort of ‘warnings’ should go on tins of snus? Modern snus use is probably around 98% less risky than smoking – but do the regulatory ‘risk communications’ in the form of these warnings really reflect that? Do they give the consumer […] The switch to 2nd generation products arrested the decline of NJOY I participated as a panel member in the Wells Fargo Securities Second Annual E-cig Conference, chaired by Bonnie Herzog, the lead beverage and tobacco sector analyst at Wells Fargo. It was a fascinating occasion and good moment to take the temperature of the […] |
|||||
Recent Comments